Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$177.26
-2.17%
Mkt Cap $127.47B
Analyst Ratings
Buy
13
Hold
3
Sell
0
Price Target (45 analysts)
$253.75
Range $220.00 – $270.00
Implied Upside
+43.2%
Consensus $253.75 vs current $177.26